Medical Devices
MD 2103 | 2013
ANIMAL/VETERINARY VACCINES MARKET [Products (Livestock - Bovine, Companion - Canine, Poultry, Equine), Diseases (Rabies, Distemper, Foot & Mouth, Gumboro, Avian Influenza, Strangles), Technology (Live attenuated, DNA, Recombinant)]
– Global Forecast to 2018 Report Description
Table of Contents List of Tables Sample Tables Related Reports About MarketsandMarkets
MarketsandMarkets North - Dominion Plaza, 17304, Preston Road, Suite 800, Dallas, TX 75252, U.S. Tel. No.: 1-888-600-6441 Email: sales@marketsandmarkets.com Website: www.marketsandmarkets.com
Animal/Veterinary Vaccines Market – Global forecast to 2018
MD 2103 2013
Report Description Key Take-aways — Definition and measurement of the global animal vaccines
— Analysis of the opportunities for stakeholders by identifying
market
the high-growth segments of the market
— Analysis of the market structure by identifying various sub-
— Strategic profiles of the key players in the global animal
segments of the animal vaccines market
vaccines market and a comprehensive analysis of their core competencies and market share
— Revenue forecast of the animal vaccines market and a
strategic analysis of each submarket with respect to individual growth trends and contribution to the overall animal vaccines market
— Analysis of the competitive developments, such as joint
ventures, alliances, mergers, acquisitions, new product/technology developments, and research and developments in the global animal vaccines market
— Revenue forecast for the animal vaccines market with respect
to Europe, North America, Asia, and the Rest of the World (RoW) — Identification of the major market trends and factors driving or
inhibiting the growth of the global animal vaccines market and its various sub-markets
Report Description The global market for animal vaccines is valued around $XX billion in 2013 and is forecast to grow at a decent CAGR of XX% by 2018 to reach $XX billion. This market is segmented by products, animal diseases, and technologies involved in developing vaccines for veterinary administration. The global animal vaccines market by products is further segmented into companion animal vaccines, livestock, poultry, porcine, equine, aquaculture, and other animal vaccines. All these product types are broadly segmented as preventive or therapeutic vaccines. Livestock vaccines and porcine vaccines are two of the largest segments, accounting for XX% of the market share globally in 2012.
next five years. Asia, parts of Africa, and LATAM are poised to grow at double-digit rates owing to the increasing investment opportunities for companies in these immature markets and the improving healthcare facilities for animals. Countries like China, India, Australia, and Brazil will be major contributors to the growth of the market. Some of the major players operating at a global level in the animal vaccines arena are Pfizer (U.S.), Merck (U.S.), SanofiAventis (France), Bayer HealthCare (Germany), Virbac (France), Novartis (Switzerland), Heska Corporation (U.S.), and Boehringer Ingelheim (Germany)
Increasing incidences of zoonotic diseases, growing prevalence of animal diseases, investments by government bodies and associations, and launches of innovative products by companies are the factors responsible for the growth of the animal vaccines market. However, increasing maintenance costs for vaccines and the shift towards vegetarian food by consumers will restrict the growth of the market to some extent. New entrants as well as established players have huge opportunities by introducing novel vaccines like DNA and recombinant vaccines and by entering into emerging countries. Europe is the largest market for animal vaccines, followed by North America. Both markets have reached the maturity phase of growth and will register mid single-digit growth rates for the
www.marketsandmarkets.com sales@marketsandmarkets.com
2
Animal/Veterinary Vaccines Market – Global forecast to 2018
MD 2103 2013
Report Description Research Methodology Market Size Estimation Both, top-down and bottom-up approaches were used to estimate and validate the size of the global animal vaccines market and its various segments and sub-segments. The research methodology used to estimate the market size also includes the following details:
All the percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All the possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. This data is consolidated and added with detailed inputs and analysis from MarketsandMarkets, and presented in this report.
The key players in the industry and markets were identified through secondary research and their market revenues were determined through primary and secondary research. They include the study of the annual and financial reports of top market players and also extensive interviews for key insights from the supply side (CEOs, directors, and marketing executives) and the demand side (veterinary physicians, veterinary hospitals, and purchase managers).
Figure 1
The following figure shows an illustrative representation of the market estimation process implemented in this study to arrive at the global market size of the product segments studied in the report
Market Size Estimation Methodology For Animal Vaccines Market, By Products
Total Animal Vaccine Market Percentage Split to Global Market (For Geography)
Arrival at global market of each product segment
Percentage Split for Each Geography, by Products Percentage Split of Sub-segments
Addition of regional level values for each product
Sub-segments
Product segment market size by region
The top-down approach was used to derive the regional market for animal vaccines. For this, the geography split was applied to the overall global market for animal vaccines. The bottom-up approach was used to arrive at the global values of the product segments by adding the regional values of the products market.
www.marketsandmarkets.com sales@marketsandmarkets.com
The following figure shows an illustrative representation of the market estimation process used to derive the global and regional market size of animal diseases and technologies in each product category
3
Animal/Veterinary Vaccines Market – Global forecast to 2018
MD 2103 2013
Report Description Figure 2
Market Size Estimation Methodology For Animal Vaccines Market, By Diseases And Technology Global animal vaccine technology & Disease Market (Market size of the region / % share)
Top -down Secondary & Primary Research
Bottom-up
Aquaculture Vaccine
Equine Vaccine
Companion Vaccine
Poultry Vaccine
Livestock Vaccine
Porcine Vaccine
By Products
Regional animal vaccine market by technology & diseases
By Technology By Geography
Live attenuated Vaccines Inactivated Vaccines
North America Toxoid vaccine Europe Conjugate vaccines Asia RoW
Subunit vaccines Recombinant vaccines DNA vaccines
The top-down approach was used to derive the animal vaccine market, by diseases and technology. Different percentage splits
Figure 3
were applied for different product markets. This percentage split was assumed to be the same in each geography
Data Triangulation Methodology (360o Evaluation)
Demand-side
Top-down
Market Data & Forecasting Bottom-up
Supply-side
The data was triangulated by studying various factors and trends from both the demand side and the supply side. Along
www.marketsandmarkets.com sales@marketsandmarkets.com
with this, the market was validated using both top-down and bottom-up approaches
4
Animal/Veterinary Vaccines Market – Global forecast to 2018
MD 2103 2013
Report Description Market Share Methodology Market shares are calculated on the basis of secondary data available through paid and unpaid sources, analyzing product portfolios of major companies, and rating them on the basis of performance and quality. These data points were further validated by primary sources
key data points from secondary Sources Parameter
Source Company financials, magazines, journals, associations, press releases, paid databases, and
Market revenues
MnM data repository World Health Organization (WHO), World Society for the Protection of Animals (WSPA), International Federation for Animal Health (IFAH), Animal Health Institute (AHI), American Pet Products Association (APPA), American Society for Microbiology, European Union commission, and Animals Asia
Market revenues of companies
— Annual reports, SEC filings, company websites, public — databases, and MnM data repository
Company website, annual reports, press releases, databases, and MnM data repository Qualitative information (Market dynamics, Market trends)
www.marketsandmarkets.com sales@marketsandmarkets.com
World Health Organization (WHO), World Society for the Protection of Animals (WSPA), International Federation for Animal Health (IFAH), Animal Health Institute (AHI), American Pet Products Association (APPA), American Society for Microbiology, European Union commission, and Animals Asia
5
Animal/Veterinary Vaccines Market – Global forecast to 2018
MD 2103 2013
Report Description Key Data Points from Primary Sources Data Points Parameter Segment The global animal vaccines market
CAGR/% Split
The global market size for 2012 and CAGR for the forecast period (2013–2018) $XX to $XX billion
XX%-XX% (CAGR)
The global animal vaccines A geographical split for the overall market in 2012 and growth trends in each geography in the forecast period (2013–2018) market, by geography : (North America, Europe, North America XX–XX% and Asia) Europe
XX–XX%
Asia
XX–XX%
A market split for product segments
The global animal vaccine market, by products
Companion animals
XX%
Livestock
XX–XX%
Poultry
XX–XX%
Porcine
XX–XX%
Equine & aquaculture
XX%
Assumptions Market
Assumptions
Geographical analysis
The overall share of all animal diseases and technologies in the global market are assumed to be the same in all the geographies/regions (North America, Europe, Asia, and RoW)
Market growth
The CAGR for the forecast period is assumed to be normalized and the effect of inflation, recession, economic downturn, regulatory or policy changes, or other factors are not considered.
www.marketsandmarkets.com sales@marketsandmarkets.com
6
Animal/Veterinary Vaccines Market – Global forecast to 2018
MD 2103 2013
Report Description Markets covered This global animal vaccines market mainly covers three segments by products, by animal disease, and by technology.
These segments are further segmented as follows:
Global Animal Vaccines Market, by Products:
§ Swine pneumonia
Ÿ Livestock vaccines
§ Others
Ÿ Poultry vaccines
Ÿ Porcine vaccines Ÿ Poultry vaccines
§ Infectious bronchitis
Ÿ Companion animal vaccines
§ Gumboro disease
Ÿ Equine vaccines
§ Avian influenza § Coccidiosis
Ÿ Aquaculture vaccines
§ Marek’s disease
Ÿ Other animal vaccines
§ Newcastle disease
Global Animal Vaccines Market, by Diseases:
§ Others
Ÿ Livestock vaccines §
Ÿ Companion animals
Bovine vaccines ¡
Foot-and-mouth disease
¡
Bovine viral diarrhea
¡
Bovine clostridial diseases
¡
Brucellosis
¡
Infectious bovine rhinotracheitis
¡
Others
§ Canine vaccines
Small ruminant clostridial diseases
¡
Scabby mouth infection
¡
Pneumonia & septicemia
¡
Pox diseases
¡
Ovine Johne's disease
¡
Others
¡
Canine distemper
¡
Canine parvovirus
¡
Infectious canine hepatitis
¡
Others
¡
Feline rabies
¡
Feline panleukopenia
¡
Feline viral rhinotracheitis
¡
Feline leukemia
¡
Others
Ÿ Equine vaccines § Equine encephalomyelitis
Ÿ Porcine vaccines
§ Strangles
§ Porcine parvovirus
§ Equine influenza
§ Porcine reproductive respiratory syndrome (PRRS)
§ Equine rhinopneumonitis
§ Porcine circovirus II
§ Others
§ Swine influenza
www.marketsandmarkets.com sales@marketsandmarkets.com
Canine rabies
§ Feline vaccines
§ Small ruminant animal vaccines ¡
¡
7
Animal/Veterinary Vaccines Market – Global forecast to 2018
MD 2103 2013
Report Description Ÿ Aquaculture vaccines
Ÿ DNA vaccines
§ Vibriosis
Ÿ Recombinant vaccines
§ Pasteurellosis
Ÿ Subunit vaccines
§ Furunculosis
Animal Vaccines Markets, by Geography:
Ÿ Others
Ÿ Europe
Ÿ Other animal vaccines
Ÿ North America
Global Animal Vaccines Markets, by Technology:
Ÿ Asia
Ÿ Inactivated vaccines
Ÿ RoW
Ÿ Live attenuated vaccines Ÿ Toxoid vaccines Ÿ Conjugate vaccines Each section of the report offers market data for various market segments and geographies. It also provides market trends with respect to drivers, restraints, and opportunities. The report also
covers the key growth strategies of the players under the section called competitive landscape
Stakeholders Ÿ Animal vaccine manufacturers
Ÿ Research institutes
Ÿ Animal healthcare product manufacturers
Ÿ Contract research organizations (CROs)
Ÿ Animal vaccine distributors and wholesalers
Ÿ Contract manufacturing organizations (CMOs)
Ÿ Animal welfare associations
Ÿ Venture capitalists
Ÿ Veterinary clinics and care centers Ÿ Various research and consulting firms
Market Scope The scope of this research study covers the global and regional market for animal vaccines, by products and animal diseases. Except the other products segment, all other segments also cover the technology market.
this market research report does not provide data tables for the technology market at the global level.
The scope of the global animal vaccines market report does not include country-level data and the market size by volume. Also,
www.marketsandmarkets.com sales@marketsandmarkets.com
8
Animal/Veterinary Vaccines Market – Global forecast to 2018
MD 2103 2013
Table of Contents Chapter Headings .....................................................................................................................Page No 1
Introduction .......................................................................................................................................22 1.1
Key Take-aways ....................................................................................................................................................22
1.2
Report Description ...............................................................................................................................................22
1.3
Research Methodology ........................................................................................................................................23
1.3.1
Market Size Estimation....................................................................................................................................23
1.3.2
Market Share...................................................................................................................................................26
1.3.3
Key Data Points from Secondary Sources ......................................................................................................27
1.3.4
Key Data Points from Primary Sources...........................................................................................................27
1.3.5
Assumptions....................................................................................................................................................28
1.4
Markets Covered...................................................................................................................................................29
1.5
Stakeholders .........................................................................................................................................................32
1.6
Market Scope ........................................................................................................................................................32
2.
Executive Summary ..........................................................................................................................33
3
Market Overview ................................................................................................................................37 3.1
Introduction ..........................................................................................................................................................38
3.2
Market Segmentation ...........................................................................................................................................38
3.3
Market Dynamics ..................................................................................................................................................40
3.3.1
Drivers ..........................................................................................................................................................40
3.3.1.1 Growing prevalence of animal diseases will result in employing preventive measures like vaccines......40 3.3.1.2 Increasing incidences of zoonotic diseases in humans will propel the vaccines market .........................41 3.3.1.3 Increasing investments by various government agencies, animal associations, & leading players to propel the market .................................................................................................................................42 3.3.1.4 Continuous innovations & introduction of new products propels the market............................................43 3.3.2
Restraints ........................................................................................................................................................44
3.3.2.1 Rising maintenance costs for storage of vaccines, a burden on manufacturers & distributors................44 3.3.2.2 Increasing adoption of vegetarian food in major economies owing to increasing risk of obesity and other chronic disorders......................................................................................................................44 3.3.2.3 Persistent economic slowdown to affect growth ......................................................................................45 3.3.3
Opportunities ...................................................................................................................................................45
3.3.3.1 Technological Innovations like DNA Vaccines ..........................................................................................45 3.3.3.2 Growing awareness of animal health in emerging economies.................................................................46 3.3.3.3 Increasing investment opportunities in emerging and immature markets ................................................47
www.marketsandmarkets.com sales@marketsandmarkets.com
9
Animal/Veterinary Vaccines Market – Global forecast to 2018
MD 2103 2013
Table of Contents Chapter Headings .....................................................................................................................Page No 3.4
Regulations for Animal Vaccines ........................................................................................................................48
3.4.1
USDA Regulates the Registration Process in U.S. .........................................................................................48
3.4.2
EMEA is the APEX Body for approval of Veterinary Vaccines in Europe ........................................................48
3.4.3
MAFF regulates the Veterinary Medicinal Products (vmps) in Japan .............................................................49
3.4.4
VICH Harmonizes the Registration Process in U.S., Europe and Japan ........................................................49
3.5
Porter’s Five Forces Analysis .............................................................................................................................50
3.5.1
Threat from New Entrants ...............................................................................................................................51
3.5.2
Threat from Substitutes ...................................................................................................................................51
3.5.3
Bargaining Power of Buyers............................................................................................................................51
3.5.4
Bargaining Power of Suppliers ........................................................................................................................51
3.5.5
Competitive Rivalry Among Existing Players...................................................................................................51
3.6
Market Share Analysis .........................................................................................................................................52
3.6.1
Global
..........................................................................................................................................................52
3.6.2
North America..................................................................................................................................................55
3.6.3
Europe ..........................................................................................................................................................56
3.6.4
Asia
..........................................................................................................................................................57
4 Global Animal Vaccines Market, by Product.......................................................................................58 4.1
Introduction...........................................................................................................................................................59
4.2
Companion Animal Vaccines...............................................................................................................................60
4.2.1
Canine Vaccines Contribute the Largest to The Companion Animal Vaccines Market ...................................61
4.2.2
Canine Vaccines..............................................................................................................................................62
4.2.3
Feline Vaccines ...............................................................................................................................................63
4.3
Livestock Vaccines...............................................................................................................................................63
4.3.1
Increasing Investments by Government Bodies and Companies ...................................................................64
4.3.2
Bovine Vaccines ..............................................................................................................................................65
4.3.3
Small Ruminant Vaccines................................................................................................................................66
4.4
Poultry Vaccines ...................................................................................................................................................66
4.5
Porcine Vaccines ..................................................................................................................................................68
4.6
Equine Vaccines ...................................................................................................................................................69
4.7
Aquaculture Vaccines ..........................................................................................................................................70
4.7.1 4.8
Aquaculture Vaccines Market to Grow at the Fastest Pace ............................................................................70
Other Animal Vaccines.........................................................................................................................................71
www.marketsandmarkets.com sales@marketsandmarkets.com
10
Animal/Veterinary Vaccines Market – Global forecast to 2018
MD 2103 2013
Table of Contents Chapter Headings .....................................................................................................................Page No 5 Global Animal Vaccines Market, by Disease.......................................................................................72 5.1
Introduction...........................................................................................................................................................73
5.2
Companion Animal Vaccines...............................................................................................................................73
5.2.1
Canine Vaccines, by Disease..........................................................................................................................73
5.2.1.1 Canine Rabies
......................................................................................................................................75
5.2.1.2 Canine Distemper ....................................................................................................................................76 5.2.1.3 Canine Parvovirus....................................................................................................................................77 5.2.1.4 Infectious Canine Hepatitis ......................................................................................................................77 5.2.2
Feline Vaccines, by Disease ...........................................................................................................................78
5.2.2.1 Feline Rabies
......................................................................................................................................79
5.2.2.2 Feline Panleukopenia...............................................................................................................................80 5.2.2.3 Feline Viral Rhinotracheitis ......................................................................................................................80 5.2.2.4 Feline Leukemia ......................................................................................................................................81 5.3
Livestock Vaccines...............................................................................................................................................82
5.3.1
Bovine Vaccines, by Disease ..........................................................................................................................82
5.3.1.1 Foot and Mouth Disease (FMD)...............................................................................................................83 5.3.1.2 Bovine Viral Diarrhea ...............................................................................................................................84 5.3.1.3 Bovine Clostridial Diseases......................................................................................................................84 5.3.1.4 Brucellosis................................................................................................................................................85 5.3.1.5 Infectious Bovine Rhinotracheitis .............................................................................................................85 5.3.2
SMALL RUMINANT VACCINES, BY DISEASE ..............................................................................................86
5.3.2.1 Small Ruminant Clostridial Diseases .......................................................................................................87 5.3.2.2 Scabby Mouth Infection............................................................................................................................88 5.3.2.3 Pneumonia & Septicemia.........................................................................................................................88 5.3.2.4 Pox Diseases ...........................................................................................................................................89 5.3.2.5 Ovine Johne's Disease (Paratuberculosis) ..............................................................................................90 5.4
Poultry Vaccines, by Disease ..............................................................................................................................90
5.4.1
Infectious Bronchitis ........................................................................................................................................91
5.4.2
Gumboro Disease ...........................................................................................................................................92
5.4.3
Avian Influenza................................................................................................................................................93
5.4.4
Coccidiosis ......................................................................................................................................................94
5.4.5
Marek’s Disease..............................................................................................................................................95
5.4.6
Newcastle Disease..........................................................................................................................................96
www.marketsandmarkets.com sales@marketsandmarkets.com
11
Animal/Veterinary Vaccines Market – Global forecast to 2018
MD 2103 2013
Table of Contents Chapter Headings .....................................................................................................................Page No 5.5
Porcine Vaccines, by Disease .............................................................................................................................98
5.5.1
Porcine Parvovirus ..........................................................................................................................................99
5.5.2
Porcine Reproductive Respiratory Syndrome (PRRS)....................................................................................99
5.5.3
Porcine Circovirus II ......................................................................................................................................100
5.5.4
Swine Influenza .............................................................................................................................................101
5.5.5
Swine Pneumonia .........................................................................................................................................101
5.6
Equine Vaccines, by Disease ............................................................................................................................102
5.6.1
Equine Encephalomyelitis .............................................................................................................................103
5.6.2
Strangles .......................................................................................................................................................103
5.6.3
Equine Influenza (Horse Flu).........................................................................................................................104
5.6.4
Equine Rhinopneumonitis .............................................................................................................................104
5.7
Aquaculture Vaccines, by Disease ...................................................................................................................105
5.7.1
Vibriosis.........................................................................................................................................................106
5.7.2
Pasteurellosis ................................................................................................................................................106
5.7.3
Furunculosis ..................................................................................................................................................107
6 Animal Vaccine Market, by Technology ............................................................................................108 6.1
Introduction.........................................................................................................................................................109
6.2
Live Attenuated Vaccines (LAV) ........................................................................................................................110
6.3
Inactivated Vaccines ...........................................................................................................................................111
6.4
Subunit Vaccines ................................................................................................................................................112
6.5
Toxoid Vaccines ..................................................................................................................................................112
6.6
Conjugate Vaccines ............................................................................................................................................113
6.7
Recombinant Vaccines.......................................................................................................................................113
6.8
DNA Vaccines......................................................................................................................................................114
6.9
Live Attenuated Technology Contributes the Largest to the Livestock Vaccines Market ...........................116
6.10
DNA Vaccines Along with Inactivated & Recombinant Technology to Grow at Healthy Pace ....................117
6.11
Inactivated Vaccines Technology Accounts for the Largest Share in Porcine Vaccine Market ..................118
7 Geographic Analysis ...........................................................................................................................121 7.1
Introduction ........................................................................................................................................................122
7.2
Europe .................................................................................................................................................................124
7.2.1 7.3
Europe Dominates the Animal Vaccine Market Owing to Highly Organized Livestock Sector ......................124
North America .....................................................................................................................................................142
7.3.1
Rise in Companion & Farm Animals to Drive The North American Market ...................................................142
www.marketsandmarkets.com sales@marketsandmarkets.com
12
Animal/Veterinary Vaccines Market – Global forecast to 2018
MD 2103 2013
Table of Contents Chapter Headings .....................................................................................................................Page No 7.3.2 7.4
Asia ......................................................................................................................................................................160
7.4.1 7.5
Increase in Investments by Companies in North America.............................................................................142
Asian Countries Offer Huge Opportunities to Vaccine Manufacturers ..........................................................160
Rest of The World (Row) ....................................................................................................................................178
8 Competitive Landscape ......................................................................................................................196 8.1
Introduction.........................................................................................................................................................197 8.1.1
More than 20 New Products were Launched Between 2012 & 2013............................................................198
8.2
Mergers & Acquisitions......................................................................................................................................199
8.3
Agreements, Partnerships, Collaborations, & Joint Ventures .......................................................................201
8.4
New Product Launch ..........................................................................................................................................202
8.5
Other Developments...........................................................................................................................................207
9 Company Profiles ................................................................................................................................210 (Overview, Financials, Products & Services, Strategy, & Developments)* 9.1
BAYER HEALTHCARE ........................................................................................................................................210
9.2
BIOGENESIS BAGO S.A.....................................................................................................................................216
9.3
BIONICHE ANIMAL HEALTH CANADA, INC. ....................................................................................................218
9.4
BOEHRINGER INGELHEIM ................................................................................................................................222
9.5
CEVA (Ceva Sante Animale) ..............................................................................................................................227
9.6
HESKA CORPORATION......................................................................................................................................231
9.7
INDIAN IMMUNOLOGICALS LTD. ......................................................................................................................235
9.8
LOHMANN ANIMAL HEALTH INTERNATIONAL ...............................................................................................239
9.9
MERCK ................................................................................................................................................................244
9.10
MERIAL (Animal Health Division of Sanofi) .....................................................................................................258
9.11
NOVARTIS ANIMAL HEALTH, INC. ....................................................................................................................262
9.12
PROTEIN SCIENCES CORPORATION...............................................................................................................267
9.13
VIRBAC ................................................................................................................................................................269
9.14
ZOETIS (Pfizer Animal Health)...........................................................................................................................274
*Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.
www.marketsandmarkets.com sales@marketsandmarkets.com
13
Animal/Veterinary Vaccines Market – Global forecast to 2018
MD 2103 2013
List of Tables Table Titles
..........................................................................................................................Page No
1
GLOBAL VETERINARY VACCINES MARKET, BY PRODUCT, 2011 – 2018 ($MILLION) ..........................................35
2
GLOBAL COMPANION ANIMAL VACCINES MARKET, BY CATEGORY, 2011 - 2018 ($MILLION)............................61
3
COMPANION ANIMAL VACCINES MARKET, BY GEOGRAPHY, 2011 - 2018 ($MILLION)........................................62
4
GLOBAL LIVESTOCK VACCINES MARKET, BY CATEGORY, 2011 - 2018 ($MILLION)............................................64
5
LIVESTOCK VACCINES MARKET, BY GEOGRAPHY, 2011 - 2018 ($MILLION)........................................................65
6
POULTRY VACCINES MARKET, BY GEOGRAPHY, 2011 - 2018 ($MILLION) ...........................................................67
7
PORCINE VACCINES MARKET, BY GEOGRAPHY, 2011 - 2018 ($MILLION) ...........................................................68
8
EQUINE VACCINES MARKET, BY GEOGRAPHY, 2011 - 2018 ($MILLION) ..............................................................69
9
AQUACULTURE VACCINES MARKET, BY GEOGRAPHY, 2011 - 2018 ($MILLION).................................................70
10
OTHER VACCINES MARKET, BY GEOGRAPHY, 2011 – 2018 ($MILLION) ..............................................................71
11
GLOBAL CANINE VACCINES MARKET, BY DISEASE, 2011 – 2018 ($MILLION) .....................................................75
12
GLOBAL FELINE VACCINES MARKET, BY DISEASE, 2011 – 2018 ($MILLION) ......................................................79
13
GLOBAL BOVINE VACCINES MARKET, BY DISEASE, 2011 –2018 ($MILLION) ......................................................83
14
GLOBAL SMALL RUMINANT VACCINES MARKET, BY DISEASE, 2011 – 2018 ($MILLION) ...................................87
15
GLOBAL POULTRY VACCINES MARKET, BY DISEASE, 2011 – 2018 ($MILLION) ..................................................91
16
COMMERCIALLY USED STRAIN FOR AVIAN INFLUENZA VACCINES ....................................................................94
17
COMMERCIALLY USED STRAIN FOR NEWCASTLE DISEASE VACCINES ............................................................97
18
GLOBAL PORCINE VACCINES MARKET, BY DISEASE, 2011 – 2018 ($MILLION) ..................................................98
19
GLOBAL EQUINE VACCINES MARKET, BY DISEASE, 2011 – 2018 ($MILLION) ...................................................102
20
GLOBAL AQUACULTURE VACCINES MARKET, BY DISEASE, 2011 – 2018 ($MILLION) ......................................105
21
GLOBAL COMPANION ANIMAL VACCINE MARKET, BY TECHNOLOGY, 2011 – 2018 ($MILLION) ......................115
22
GLOBAL LIVESTOCK VACCINE MARKET, BY TECHNOLOGY, 2011 – 2018 ($MILLION) ......................................116
23
GLOBAL POULTRY VACCINE MARKET, BY TECHNOLOGY, 2011 – 2018 ($MILLION)..........................................117
24
GLOBAL PORCINE VACCINE MARKET, BY TECHNOLOGY, 2011 – 2018 ($MILLION) ..........................................118
25
GLOBAL EQUINE VACCINE MARKET, BY TECHNOLOGY, 2011 – 2018 ($MILLION).............................................119
26
GLOBAL AQUACULTURE VACCINE MARKET, BY TECHNOLOGY, 2011 – 2018 ($MILLION) ...............................120
27
NUMBER OF CATTLE IN EUROPE, 2010 & 2011 (THOUSAND HEAD) ..................................................................124
28
EUROPE: VETERINARY VACCINES MARKET, BY PRODUCT, 2011 – 2018 ($MILLION) ......................................125
29
EUROPE: COMPANION ANIMAL VACCINES MARKET, BY CATEGORY, 2011 – 2018 ($MILLION) .......................126
30
EUROPE: CANINE VACCINES MARKET, BY DISEASE, 2011 – 2018 ($MILLION) .................................................127
31
EUROPE: FELINE VACCINES MARKET, BY DISEASE, 2011 – 2018 ($MILLION) ..................................................128
32
EUROPE: COMPANION ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2011 – 2018 ($MILLION)..................129
www.marketsandmarkets.com sales@marketsandmarkets.com
14
Animal/Veterinary Vaccines Market – Global forecast to 2018
MD 2103 2013
List of Tables Table Titles
..........................................................................................................................Page No
33
EUROPE: LIVESTOCK VACCINES MARKET, BY CATEGORY, 2011 – 2018 ($MILLION) .......................................130
34
EUROPE: BOVINE VACCINES MARKET, BY DISEASE, 2011 – 2018 ($MILLION) .................................................131
35
EUROPE: SMALL RUMINANT VACCINES MARKET, BY DISEASE, 2011 – 2018 ($MILLION) ...............................132
36
EUROPE: LIVESTOCK VACCINES MARKET, BY TECHNOLOGY, 2011 – 2018 ($MILLION)..................................133
37
EUROPE: POULTRY VACCINES MARKET, BY DISEASE, 2011 – 2018 ($MILLION) ..............................................134
38
EUROPE: POULTRY VACCINES MARKET, BY TECHNOLOGY, 2011 – 2018 ($MILLION) .....................................135
39
EUROPE: PORCINE VACCINES MARKET, BY DISEASE, 2011 – 2018 ($MILLION) ..............................................136
40
EUROPE: PORCINE VACCINES MARKET, BY TECHNOLOGY, 2011 – 2018 ($MILLION) .....................................137
41
EUROPE: EQUINE VACCINES MARKET, BY DISEASE, 2011 – 2018 ($MILLION) .................................................138
42
EUROPE: EQUINE VACCINES MARKET, BY TECHNOLOGY, 2011 – 2018 ($MILLION) ........................................139
43
EUROPE: AQUACULTURE VACCINES MARKET, BY DISEASE, 2011 – 2018 ($MILLION) ....................................140
44
EUROPE: AQUACULTURE VACCINES MARKET, BY TECHNOLOGY, 2011 – 2018 ($MILLION) ...........................141
45
NORTH AMERICA: VETERINARY VACCINES MARKET, BY PRODUCT, 2011 – 2018 ($MILLION) .......................143
46
NORTH AMERICA: COMPANION ANIMAL VACCINES MARKET, BY CATEGORY, 2011 – 2018 ............................144
47
NORTH AMERICA: CANINE VACCINES MARKET, BY DISEASE, 2011 – 2018 ($MILLION)...................................145
48
NORTH AMERICA: FELINE VACCINES MARKET, BY DISEASE, 2011 – 2018 ($MILLION)....................................146
49
NORTH AMERICA: COMPANION ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2011 – 2018 ($MILLION) ...147
50
NORTH AMERICA: LIVESTOCK VACCINES MARKET, BY CATEGORY, 2011 – 2018 ($MILLION) ........................148
51
NORTH AMERICA: BOVINE VACCINES MARKET, BY DISEASE, 2011 – 2018 ($MILLION)...................................149
52
NORTH AMERICA: SMALL RUMINANT VACCINES MARKET, BY DISEASE, 2011 – 2018 ($MILLION).................150
53
NORTH AMERICA: LIVESTOCK VACCINES MARKET, BY TECHNOLOGY, 2011 – 2018 ($MILLION) ...................151
54
NORTH AMERICA: POULTRY VACCINES MARKET, BY DISEASE, 2011 – 2018 ($MILLION)................................152
55
NORTH AMERICA: POULTRY VACCINES MARKET, BY TECHNOLOGY, 2011 – 2018 ($MILLION) ......................153
56
NORTH AMERICA: PORCINE VACCINES MARKET, BY DISEASE, 2011 – 2018 ($MILLION)................................154
57
NORTH AMERICA: PORCINE VACCINES MARKET, BY TECHNOLOGY, 2011 – 2018 ($MILLION).......................155
58
NORTH AMERICA: EQUINE VACCINES MARKET, BY DISEASE, 2011 – 2018 ($MILLION) ..................................156
59
NORTH AMERICA: EQUINE VACCINES MARKET, BY TECHNOLOGY, 2011 – 2018 ($MILLION) .........................157
60
NORTH AMERICA: AQUACULTURE VACCINES MARKET, BY DISEASE, 2011 – 2018 ($MILLION) .....................158
61
NORTH AMERICA: AQUACULTURE VACCINES MARKET, BY TECHNOLOGY, 2011 – 2018 ($MILLION) ............159
62
ASIA: VETERINARY VACCINES MARKET, BY PRODUCT, 2011 – 2018 ($MILLION) .............................................161
63
ASIA: COMPANION ANIMAL VACCINES MARKET, BY CATEGORY,2011 – 2018 ($MILLION) ...............................162
www.marketsandmarkets.com sales@marketsandmarkets.com
15
Animal/Veterinary Vaccines Market – Global forecast to 2018
MD 2103 2013
List of Tables Table Titles
..........................................................................................................................Page No
64
ASIA: CANINE VACCINES MARKET, BY DISEASE, 2011 – 2018 ($MILLION) ........................................................163
65
ASIA: FELINE VACCINES MARKET, BY DISEASE, 2011 – 2018 ($MILLION) .........................................................164
66
ASIA: COMPANION ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2011 – 2018 ($MILLION).........................165
67
ASIA: LIVESTOCK VACCINES MARKET, BY CATEGORY, 2011 – 2018 ($MILLION) ..............................................166
68
ASIA: BOVINE VACCINES MARKET, BY DISEASE, 2011 – 2018 ($MILLION) ........................................................167
69
ASIA: SMALL RUMINANT VACCINES MARKET, BY DISEASE, 2011 – 2018 ($MILLION) ......................................168
70
ASIA: LIVESTOCK VACCINES MARKET, BY TECHNOLOGY, 2011 – 2018 ($MILLION).........................................169
71
ASIA: POULTRY VACCINES MARKET, BY DISEASE, 2011 – 2018 ($MILLION) .....................................................170
72
ASIA: POULTRY VACCINES MARKET, BY TECHNOLOGY, 2011 – 2018 ($MILLION) ............................................171
73
ASIA: PORCINE VACCINES MARKET, BY DISEASE, 2011 – 2018 ($MILLION) .....................................................172
74
ASIA: PORCINE VACCINES MARKET, BY TECHNOLOGY, 2011 – 2018 ($MILLION) ............................................173
75
ASIA: EQUINE VACCINES MARKET, BY DISEASE, 2011 – 2018 ($MILLION) ........................................................174
76
ASIA: EQUINE VACCINES MARKET, BY TECHNOLOGY, 2011 – 2018 ($MILLION) ...............................................175
77
ASIA: AQUACULTURE VACCINES MARKET, BY DISEASE, 2011 – 2018 ($MILLION) ...........................................176
78
ASIA: AQUACULTURE VACCINES MARKET, BY TECHNOLOGY, 2011 – 2018 ($MILLION) ..................................177
79
ROW: VETERINARY VACCINES MARKET, BY PRODUCT, 2011 – 2018 ($BILLION) .............................................179
80
ROW: COMPANION ANIMAL VACCINES MARKET, BY CATEGORY, 2011 – 2018 ($MILLION)..............................180
81
ROW: CANINE VACCINES MARKET, BY DISEASE, 2011 – 2018 ($MILLION)........................................................181
82
ROW: FELINE VACCINES MARKET, BY DISEASE, 2011 – 2018 ($MILLION).........................................................182
83
ROW: COMPANION ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2011 – 2018 ($MILLION) ........................183
84
ROW: LIVESTOCK VACCINES MARKET, BY CATEGORY, 2011 – 2018 ($MILLION) .............................................184
85
ROW: BOVINE VACCINES MARKET, BY DISEASE, 2011 – 2018 ($MILLION)........................................................185
86
ROW: SMALL RUMINANT VACCINES MARKET, BY DISEASE, 2011 – 2018 ($MILLION)......................................186
87
ROW: LIVESTOCK VACCINES MARKET, BY TECHNOLOGY, 2011 – 2018 ($MILLION) ........................................187
88
ROW: POULTRY VACCINES MARKET, BY DISEASE, 2011 – 2018 ($MILLION).....................................................188
89
ROW: POULTRY VACCINES MARKET, BY TECHNOLOGY, 2011 – 2018 ($MILLION)............................................189
90
ROW: PORCINE VACCINES MARKET, BY DISEASE, 2011 – 2018 ($MILLION) .....................................................190
91
ROW: PORCINE VACCINES MARKET, BY TECHNOLOGY, 2011 – 2018 ($MILLION)............................................191
92
ROW: EQUINE VACCINES MARKET, BY DISEASE, 2011 – 2018 ($MILLION)........................................................192
93
ROW: EQUINE VACCINES MARKET, BY TECHNOLOGY, 2011 – 2018 ($MILLION) ..............................................193
94
ROW: AQUACULTURE VACCINES MARKET, BY DISEASE, 2011 – 2018 ($MILLION)...........................................194
www.marketsandmarkets.com sales@marketsandmarkets.com
16
Animal/Veterinary Vaccines Market – Global forecast to 2018
MD 2103 2013
List of Tables Table Titles
..........................................................................................................................Page No
95
ROW: AQUACULTURE VACCINES MARKET, BY TECHNOLOGY, 2011 – 2018 ($MILLION)..................................195
96
MERGERS & ACQUISITIONS (2011 – 2013) ............................................................................................................199
97
AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, & JOINT VENTURES (2011 – 2013)...............................201
98
NEW PRODUCT LAUNCH (2011 – 2013)..................................................................................................................202
99
OTHER DEVELOPMENTS (2011 – 2012) .................................................................................................................207
www.marketsandmarkets.com sales@marketsandmarkets.com
17
Animal/Veterinary Vaccines Market – Global forecast to 2018
MD 2103 2013
List of Figures Figure Titles
..........................................................................................................................Page No
1
MARKET SIZE ESTIMATION METHODOLOGY FOR ANIMAL VACCINES MARKET, BY PRODUCTS ....................24
2
MARKET SIZE ESTIMATION METHODOLOGY FOR ANIMAL VACCINES MARKET, BY DISEASES AND TECHNOLOGY ............................................................................................................................................................25
3
DATA TRIANGULATION METHODOLOGY (360O EVALUATION) ..............................................................................26
4
VETERINARY VACCINES MARKET, BY GEOGRAPHY (%) & BY PRODUCTS ($MILLION), 2013 ..........................34
5
ANIMAL VACCINES MARKET SEGMENTATION ........................................................................................................39
6
MARKET DYNAMICS...................................................................................................................................................40
7
PORTER’S FIVE FORCES ANALYSIS ........................................................................................................................50
8
GLOBAL ANIMAL VACCINES MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2012.............................................52
9
NORTH AMERICA: ANIMAL VACCINE MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2012 ..............................55
10
EUROPE: ANIMAL VACCINE MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2012 .............................................56
11
ASIA: ANIMAL VACCINE MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2012 ....................................................57
12
OPPORTUNITY MATRIX: GLOBAL VETERINARY VACCINES MARKET, BY PRODUCT, 2011 - 2018 ($MILLION) ...............................................................................................................................................59
13
GLOBAL CANINE VACCINES MARKET, BY DISEASE, 2013 ($MILLION) .................................................................74
14
GLOBAL FELINE VACCINES MARKET, BY DISEASE, 2013 ($MILLION) ..................................................................78
15
TECHNOLOGY EVOLUTION.....................................................................................................................................109
16
GLOBAL LIVE ATTENUATED ANIMAL VACCINES MARKET, BY PRODUCT, 2013 & 2018 ($MILLION) ................110
17
VETERINARY VACCINES MARKET, BY GEOGRAPHY, 2013..................................................................................122
18
ANIMAL VACCINES MARKET, GROWTH PHASES, BY GEOGRAPHY, 2013 .........................................................123
19
GEOGRAPHIC REACH VS PRODUCT PORTFOLIO ANALYSIS: KEY PLAYERS...................................................196
20
KEY GROWTH STRATEGIES, 2010 – 2013..............................................................................................................197
21
BAYER HEALTHCARE: TOTAL REVENUE ($MILLION) AND OPERATING MARGIN (%), 2010 – 2012 .................211
22
BAYER HEALTHCARE: BUSINESS REVENUE MIX, 2012 .......................................................................................211
23
BAYER HEALTHCARE: GEOGRAPHIC REVENUE MIX, 2012.................................................................................212
24
BAYER HEALTHCARE: MARKET STRATEGY, 2011 – 2013 ....................................................................................214
25
BIONICHE: TOTAL REVENUE ($MILLION), 2010 – 2012 .........................................................................................219
26
BIONICHE: BUSINESS REVENUE MIX, 2012 ..........................................................................................................219
27
BIONICHE: GEOGRAPHIC REVENUE MIX, 2012 ....................................................................................................220
28
BOEHRINGER INGELHEIM: TOTAL REVENUE ($MILLION) AND OPERATING MARGIN (%), 2010 – 2012 .........223
29
BOEHRINGER INGELHEIM: BUSINESS REVENUE MIX, 2012...............................................................................223
30
CEVA: TOTAL REVENUE ($MILLION), 2010 – 2011 .................................................................................................228
31
HESKA: TOTAL REVENUE ($MILLION) AND OPERATING MARGIN (%), 2010 – 2012 ..........................................232
32
HESKA: BUSINESS REVENUE MIX, 2012 ...............................................................................................................232
33
HESKA: GEOGRAPHIC REVENUE MIX, 2012 .........................................................................................................233
34
MERCK: TOTAL REVENUE ($MILLION) AND OPERATING MARGIN (%), 2010 – 2012 .........................................245
www.marketsandmarkets.com sales@marketsandmarkets.com
18
Animal/Veterinary Vaccines Market – Global forecast to 2018
MD 2103 2013
List of Figures Figure Titles
..........................................................................................................................Page No
35
MERCK ANIMAL HEALTH: BUSINESS REVENUE MIX, 2011 ..................................................................................245
36
MERCK: GEOGRAPHIC REVENUE MIX, 2011.........................................................................................................246
37
MERCK: MARKET STRATEGY, 2011 – 2013 ............................................................................................................255
38
MERIAL: TOTAL REVENUE ($MILLION), 2010 – 2012 .............................................................................................259
39
MERIAL: MARKET STRATEGY, 2011 – 2013 ............................................................................................................260
40
NOVARTIS: TOTAL REVENUE ($MILLION), 2010 – 2012 ........................................................................................263
41
NOVARTIS: BUSINESS REVENUE MIX, 2012..........................................................................................................263
42
NOVARTIS: GEOGRAPHIC REVENUE MIX, 2012 ...................................................................................................264
43
VIRBAC: TOTAL REVENUE ($MILLION), 2010 – 2012 .............................................................................................270
44
VIRBAC: BUSINESS REVENUE MIX, 2012 ..............................................................................................................270
45
VIRBAC: GEOGRAPHIC REVENUE MIX, 2012 ........................................................................................................271
46
VIRBAC, MARKET STRATEGY, 2011 – 2013 ............................................................................................................272
47
ZOETIS: TOTAL REVENUE ($MILLION) AND OPERATING MARGIN (%), 2010 – 2012 .........................................275
48
ZOETIS: BUSINESS REVENUE MIX, 2012...............................................................................................................275
49
ZOETIS: GEOGRAPHIC REVENUE MIX, 2012 ........................................................................................................276
50
ZOETIS, MARKET STRATEGY, 2011 – 2013 ............................................................................................................279
www.marketsandmarkets.com sales@marketsandmarkets.com
19
Animal/Veterinary Vaccines Market – Global forecast to 2018
MD 2103 2013
Sample Tables Global Veterinary Vaccines Market, by Product, 2011 - 2018 ($Million) Category
2011
2012
2013
2018
CAGR% (2013-2018)
Livestock Vaccines Porcine Vaccines Poultry Vaccines
e l p am
Companion Animal Vaccines Equine Vaccines Aquaculture Vaccines
s e l b Ta
S
Other Animal Vaccines Total
Companion Animal Vaccines Market, by Geography, 2011 - 2018 ($Million) Region
2011
2012
2018
CAGR% (2013-2018)
s e l b a T ple
Europe North America Asia
2013
Sam
RoW Total
Equine Vaccines Market, by Geography, 2011 - 2018 ($Million) Region
2011
2012
North America
RoW Total
www.marketsandmarkets.com sales@marketsandmarkets.com
2018
s e l b a T ple
Europe
Asia
2013
Sam
20
CAGR% (2013-2018)
Animal/Veterinary Vaccines Market – Global forecast to 2018
MD 2103 2013
Disclaimer MarketsandMarkets strategic analysis services are limited publications containing valuable market information provided to a select group of customers in response to orders. Our customers acknowledge, when ordering, that MarketsandMarkets strategic analysis services are for our customers' internal use and not for general publication or disclosure to third parties. Quantitative market information is based primarily on interviews and therefore, is subject to fluctuation. MarketsandMarkets does not endorse any vendor, product or service depicted in its research publications. MarketsandMarkets strategic analysis publications consist of the opinions of MarketsandMarkets' research and should not be construed as statements of fact. MarketsandMarkets disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose. MarketsandMarkets takes no responsibility for any incorrect information supplied to us by manufacturers or users. All trademarks, copyrights and other forms of intellectual property belong to their respective owners and may be protected by copyright. Under no circumstance may any of these be reproduced in any form without the prior written agreement of their owner. No part of this strategic analysis service may be given, lent, resold or disclosed to non-customers without written permission. Reproduction and/or transmission in any form and by any means including photocopying, mechanical, electronic, recording or otherwise, without the permission of the publisher is prohibited.
For information regarding permission, contact: Tel: 1-888-600-6441 Email: sales@marketsandmarkets.com
Copyright Š 2013 MarketsandMarkets All Rights Reserved. This document contains highly confidential information and is the sole property of MarketsandMarkets. No part of it may be circulated, copied, quoted, or otherwise reproduced without the approval of MarketsandMarkets.
www.marketsandmarkets.com sales@marketsandmarkets.com
21
Animal/Veterinary Vaccines Market – Global forecast to 2018
MD 2103 2013
About MarketsandMarkets We publish about 120 reports a year across 10 main industries. The reports are exhaustive, detailing about 50 micro markets and product segments, and featuring about 80 to 100 market data summary tables, 50 short company profiles, a five-level market breakdown, overviews of more than 300 patents, as well as analyses of the strategic and competitive landscape.
Our clients value our reports especially for the market insight we provide along with the market numbers. Our teams of specialized market analysts and domain experts work within a structured research process to deliver well-analyzed market reports to Fortune 1000 companies globally.
Click here to learn more about us
Related Reports European Home Healthcare Market By Products (Blood Glucose Meter, ECG, IV Equipment, Nutrition, Wheelchair, Fitness, Heart Rate Monitor, Pregnancy Test Kit), Services (Respiratory Therapy, Rehabilitation Therapy) & Telehealth – Forecasts to 2017 The Europe home healthcare market is segmented as products, services, telehealth, and geography. The products market is further classified into homecare testing, screening & monitoring devices, home healthcare therapeutic equipment, mobility assist & other devices, and nutrition and fitness. The home healthcare services market is further segmented into unskilled care, rehabilitation therapy, infusion therapy and respiratory therapy, while the telehealth market includes monitoring devices, services, and managed equipment services. The total market is divided into seven major countries, i.e. Germany, France, U.K., Italy Spain, Russia, and Rest of Europe (RoE) Report Code: MD 2070
Lab Automation Market by Equipment & Software (Automated Liquid Handling & Robotics, Microplate Readers, LIMS and Automated Storage), and Applications (Drug Discovery, Clinical Diagnostics, Genomics, Proteomics) – Trends & Global Forecasts to 2017 Laboratory automation is defined as the use of technology to streamline or substitute manual manipulation of equipment and processes. Laboratory automation offers technologies and engineering backing for state-of-the-art work flows in research, quality assurance, and diagnostics labs. Report Code: MD 2023
www.marketsandmarkets.com sales@marketsandmarkets.com
22